MEGAN WILSON: Open Payments
NPI 1336920503 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Integra LifeSciences Corporation | 1 | $41 |
| ABBVIE INC. | 2 | $40 |
| Eisai Inc. | 1 | $31 |
| MOTIVA USA, LLC | 1 | $24 |
| Davol Inc. | 1 | $20 |
| Genmab U.S., Inc. | 1 | $19 |
Products named: LYNPARZA, KEYTRUDA, CODMAN CERTAS, ELAHERE, Lenvima, Motiva Implant Matrix, Tivdak.
Industry payments across OK — which companies pay providers there.
